LifeStance Health Group, a major provider of outpatient mental health care, announced a secondary public offering of 45 million shares by existing stockholders, with the company itself not selling any shares or receiving proceeds. Concurrently, LifeStance authorized the repurchase of 2 million shares at the same price as the offering, subject to completion of the offering. Barclays and J.P. Morgan are underwriting the offering. This move allows stockholders to liquidate shares while the company maintains some control via the repurchase option, reflecting ongoing financial management amid its growth in mental health services across the U.S.
LifeStance Health Group shares are currently priced at USD 12.99 on Pluang, down 5.66% in the last day. The stock has a market cap of $5.24 billion and a 52-week high of $14.21 as of Nov 09, 2026 19:02 WIB.
